Pluristem Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pluristem Therapeutics

PSTI 8.720

+0.2%

Aug 14 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: xcentral1	9/23/2008 8:47:09 AM
	Read Replies (1) of 295

Pluristem Therapeutics Inc. (Nasdaq: PSTI) today announced it has entered into definitive agreements to sell common stock and warrants for aggregate gross proceeds of $1,035,000. The offering is made pursuant to the Form S-3 shelf registration statement that was filed by Pluristem with the SEC and declared effective by the SEC on July 1, 2008. The securities sold in the offering were 900,000 shares of common stock at a price of $1.15 per share and a five-year warrant to purchase 675,000 shares of common stock at an exercise price of $1.90 per share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next